Zdrowie i gospodarka · 12/11/2002

FDA Releases Draft Guidance on Electronic Records and Electronic Signatures

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the agency's expectations for electronic records and electronic signatures in the pharmaceutical industry, with the goal of ensuring the accuracy, completeness, and reliability of these records for regulatory purposes.